Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-23

Clinical Trial Update: A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing oxycodone to oxycodone/naloxone in moderate to severe chronic cancer pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxycodone (oxycodone)
  • Oxycodone/Naloxone (oxycodone/naloxone)

Snippet

Sponsor: Mundipharma Research GmbH & Co KG | Conditions: Cancer, Pain | Phase 2 | Status: COMPLETED